ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $448,000 | -7.1% | 91,314 | 0.0% | 0.12% | -10.8% |
| Q2 2021 | $482,000 | +10.0% | 91,314 | 0.0% | 0.14% | +9.4% |
| Q1 2021 | $438,000 | +10.1% | 91,314 | -0.5% | 0.13% | -4.5% |
| Q4 2020 | $398,000 | +4.5% | 91,807 | -0.6% | 0.13% | -7.0% |
| Q3 2020 | $381,000 | +60.1% | 92,357 | -0.7% | 0.14% | +45.9% |
| Q2 2020 | $238,000 | -10.2% | 92,997 | +1.3% | 0.10% | -26.9% |
| Q1 2020 | $265,000 | -23.4% | 91,814 | +0.5% | 0.13% | -3.6% |
| Q4 2019 | $346,000 | -43.2% | 91,314 | 0.0% | 0.14% | -44.6% |
| Q3 2019 | $609,000 | +7.6% | 91,314 | 0.0% | 0.25% | +5.9% |
| Q2 2019 | $566,000 | -12.8% | 91,314 | 0.0% | 0.24% | -9.2% |
| Q1 2019 | $649,000 | -16.8% | 91,314 | 0.0% | 0.26% | -18.9% |
| Q4 2018 | $780,000 | -25.9% | 91,314 | 0.0% | 0.32% | -25.1% |
| Q3 2018 | $1,052,000 | -55.4% | 91,314 | 0.0% | 0.43% | -51.8% |
| Q2 2018 | $2,359,000 | +8.1% | 91,314 | 0.0% | 0.89% | +10.7% |
| Q1 2018 | $2,182,000 | -33.8% | 91,314 | -6.2% | 0.81% | -32.8% |
| Q4 2017 | $3,298,000 | +26.3% | 97,314 | -21.1% | 1.20% | +18.5% |
| Q3 2017 | $2,611,000 | +21.0% | 123,314 | 0.0% | 1.01% | +12.6% |
| Q2 2017 | $2,157,000 | -0.0% | 123,314 | 0.0% | 0.90% | -3.6% |
| Q1 2017 | $2,158,000 | +3.6% | 123,314 | 0.0% | 0.93% | -2.7% |
| Q4 2016 | $2,084,000 | +3.0% | 123,314 | 0.0% | 0.96% | +2.1% |
| Q3 2016 | $2,024,000 | +8.4% | 123,314 | 0.0% | 0.94% | +4.1% |
| Q2 2016 | $1,867,000 | +4.7% | 123,314 | 0.0% | 0.90% | +5.4% |
| Q1 2016 | $1,783,000 | – | 123,314 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|